Increase in prostate cancer screening after rollout of revised national guidelines
GlobalData epidemiologists expect that the rise in prostate cancer screening may lead to an increase in diagnosed cases in the…
By
GlobalData epidemiologists expect that the rise in prostate cancer screening may lead to an increase in diagnosed cases in the…
ByOptions for male contraception are still extremely limited, with only 31 clinical trials ongoing at the most recent count.
ByThe safety profile of Xtandi in treatment arms was in line with the results from the initial analysis.
TALAPRO-3 will enrol 550 men with DDR-deficient mCSPC at about 285 sites in 28 countries.
Telix Pharmaceuticals has begun a Phase III ProstACT clinical trial of its therapy candidate, TLX591 (177Lu-DOTA-rosopatamab), in advanced metastatic castrate-resistant…
Prostate cancers are slow-moving tumours and are generally regarded as immunologically “cold”.
ByAstraZeneca and MSD have reported positive results from the Phase III PROfound trial evaluating the safety and efficacy of Lynparza…
Late-stage clinical biopharmaceutical company Sophiris Bio has received positive feedback from the European Medicines Agency (EMA) for the Phase III…